As of June 2024 Editas Medicine has a market cap of $0.41 Billion. This makes Editas Medicine the world's 6221th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.41 B | -49.65% |
2023 | $0.82 B | 35.65% |
2022 | $0.60 B | -66.41% |
2021 | $1.81 B | -58.45% |
2020 | $4.37 B | 171.53% |
2019 | $1.60 B | 45.09% |
2018 | $1.10 B | -14.3% |
2017 | $1.29 B | 117.56% |
2016 | $0.59 B |
On Jun 17th, 2024 the market cap of Editas Medicine was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $12.64 M | -96.96% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.38 B | -8.75% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $1.97 B | 373.77% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $2.10 B | 404.55% | Jersey |